The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis-Reference-Cited by-同舟云学术

The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis

Published:2018-05 Issue: Volume:125 Page:69-77
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Ciliberto Domenico,Staropoli Nicoletta,Caglioti Francesca,Chiellino Silvia,Ierardi Antonella,Ingargiola Rossana,Botta Cirino,Arbitrio Mariamena,Correale Pierpaolo,Tassone Pierfrancesco,Tagliaferri Pierosandro

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference70 articles.

1. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994

2. 2017. colon cancer, version 1. NCCN clinical practice guidelines in oncology;Benson;J. Natl. Compr. Cancer Netw.,2017

3. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies;Boeckx;Ann. Oncol.,2017

4. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J. Clin. Oncol.,2009

5. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials;Bokemeyer;Eur. J. Cancer,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Predictive Role of Circulating Inflammatory Biomarkers in the Response to Cetuximab-Based Therapy for unresectable stage IV Metastatic Colorectal Cancer;Journal of Medical and Radiation Oncology;2024-07-27

2. The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2024-01

3. Individual approach to metastatic colorectal cancer treatment (clinical cases);Koloproktologia;2023-12-21

4. First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis;Heliyon;2023-08

5. Anti-EGFR Therapy for Left-Sided RAS Wild-type Colorectal Cancer—PARADIGM Shift;JAMA Oncology;2023-06-01